Biological Products, (No Diagnostic Substances) · I0 · CIK 1613780
DBV Technologies develops epicutaneous immunotherapy for food allergies
Comparable business profile · signals at a glance
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 29, 2026 | Mohideen PharisChief Medical Officer | Sell | 534 | $4.86 | $3K |
| Dec 18, 2025 | Epic BpifranceOther | Sell | 1,292,103 | $4.19 | $5.4M |
| Dec 17, 2025 | Epic BpifranceOther | Sell | 2,036,990 | $4.84 | $9.9M |
| Dec 17, 2025 | Epic BpifranceOther | Sell | 40,000 | $5.28 | $211K |
| Nov 21, 2025 | Mohideen PharisChief Medical Officer | Sell | 1,624 | $2.77 | $4K |
| Nov 20, 2025 | Mohideen PharisChief Medical Officer | Sell | 6,496 | $2.88 | $19K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.